Pfizer to Test 3rd COVID Shot in Kids Under 5 After Two Doses Fall Short • Children's Health Defense
"Pfizer and BioNTech will test a third dose of their COVID vaccine on infants and children 6 months to 5 years old after the company said two doses failed to trigger a sufficient immune response in 2- to 5-year-olds.
"The companies said on Dec. 17 they amended their clinical trial to include a third shot for the age group at least two months after the initial two-dose regimen.
"The companies tested a 3 microgram dose of the vaccine — one-tenth of the adult dose — in children 6 months to 5 years of age. After two doses, children between 6 months and 2 years produced an immune response comparable to people aged 16 to 25 years, but children between 2 and 5 years old did not."
https://childrenshealthdefense.org/defender/pfizer-test-third-covid-shot-kids-under-five/
No comments:
Post a Comment